Project Grant R21TW012842
- Federal Grant Award Summary Makerere University College of Health Sciences received a $1,074,068 Project Grant from the Fogarty International Center (FIC) beginning August 1, 2025, and extending through March 31, 2030, to support "Scaling Up Advanced Genomics and Bioinformatics Research Training in Pediatric HIV/AIDS in Uganda." This award addresses critical capacity-building needs in sub-Saharan Africa, where the highest burden of HIV disease globally persists. The project will...
- Federal Grant Award Summary The Fogarty International Center (FIC), under the Department of Health and Human Services National Institutes of Health, awarded Makerere University College of Health Sciences a Project Grant totaling $303,316 on September 15, 2025, through the International Research and Research Training program (CFDA 93.989). The H-DATA (Harnessing Health Data Science Capacity to Strengthen Evidence-Based Interventions, Policy and Response to the HIV/AIDS Epidemic in Uganda)...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded the University of Southern California a $14.74 million Project Grant (CFDA 93.837 – Cardiovascular Diseases Research) on September 5, 2025, for a five-year research initiative focused on developing an HIV cure through in vivo cell engineering. The award, scheduled for completion by June 30, 2030, represents a coordinated multi-institutional research program designed to advance gene and cell therapy...
- Federal Grant Award Summary The John E. Fogarty International Center (FIC) at the National Institutes of Health awarded a Project Grant of $899,426 to the University of California, Davis under the International Research and Research Training program (CFDA 93.989), effective September 22, 2025, with completion targeted for August 31, 2030. This Mentored International Research Scientist Development Award (K01) supports Dr. Cameron Gaskill, Assistant Professor of Surgery, in establishing an...
- Federal Grant Award Summary Award Details: The National Heart, Lung, and Blood Institute (NHLBI) awarded Emory University a Project Grant totaling $646,383 under the Cardiovascular Diseases Research program (CFDA 93.837). The award was obligated on September 15, 2025, with an ultimate completion date of June 30, 2030. Research Scope and Deliverables: This project investigates red blood cell (RBC) transfusion survival and effectiveness in recipients with sickle cell disease (SCD), a clinical...
- Federal Grant Award Summary Case Western Reserve University received a $235,500 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective April 17, 2026, with a completion date of March 31, 2028. The research will be conducted at the university's Cleveland, Ohio location in affiliation with University Hospitals of Cleveland. This project investigates cell-free hemoglobin (CFH)...
- Summary of Federal Grant Award The Infectious Diseases Institute Limited (IDI) in Uganda received a $302,160 Project Grant award effective July 1, 2025, through February 29, 2028, under the International Research and Research Training program (CFDA 93.989) administered by the John E. Fogarty International Center. The High-Performance Computing for HIV Research Excellence (HPC4HIV) initiative aims to strengthen IDI's computational research infrastructure and capacity to support HIV research and...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded The Regents of the University of California, San Francisco a $3.26 million Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) for a four-year period beginning September 1, 2025. This research initiative investigates immune activation and region-specific myocardial arrhythmic substrate in sudden cardiac death (SCD) victims with HIV. The study builds upon the investigators'...
- Summary of Federal Project Grant Award The Fogarty International Center awarded a $169,015 Project Grant on September 16, 2025, under the International Research and Research Training program (CFDA 93.989) to support Dr. Dickens Onyango's research and career development at Kenyatta National Hospital in Kenya. The award funds the development and evaluation of a urine dipstick-guided counseling intervention designed to enhance adherence and completion of the three-month isoniazid with rifapentine...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Massachusetts General Hospital $1.52 million under the Allergy and Infectious Diseases Research program (CFDA 93.855) on September 23, 2025, to conduct the LOW-V Africa Study, a five-year longitudinal research initiative examining low-level HIV viremia (LLV) among individuals receiving tenofovir, lamivudine, and dolutegravir (TLD) antiretroviral therapy in South Africa. The study will...
Safe Blood For Africa Foundation received a $156,179 Project Grant from the Fogarty International Center under the International Research and Research Training program (CFDA 93.989) for the period June 1, 2026 through May 31, 2028. The award funds the Effect of HIV Infection on Sickle Cell Disease Outcomes (EFHISA) study, which will establish a clinical registry in Cameroon to measure HIV prevalence and characterize demographic and clinical characteristics among sickle cell disease (SCD) patients. The project addresses a critical knowledge gap regarding the effects of HIV infection on SCD outcomes, which currently lack sufficient evidence to guide clinical management in the United States. The research will screen approximately 866 registered SCD patients in Cameroon to confirm HIV status and identify previously undiagnosed HIV-positive cases. The study leverages Cameroon's higher HIV prevalence and presence of four of the five SCD genotypes found in Central Africa to generate findings applicable to U.S. medical care. By examining the relationship between HIV infection, SCD severity across different genotypes, and treatment outcomes, the project will produce evidence-based insights to inform the clinical management of this comorbidity in the American patient population. The research aligns with the Fogarty International Center's mission to reduce global health disparities through collaborative international research and evidence generation on critical health challenges in low- and middle-income countries.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $156.2k | 5/27/26 |